PerkinElmer Inc (PKN MU) stock market data APIs
€86.2411
0(0%)
as of December 15, 2025
Try our APIs with
free plan!
PerkinElmer Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for PKN.MU.
Prev. Close
86.2411
Open
86.2411
High
86.2411
Low
86.2411
52 wk Range
70.9058-121.4807
Market Cap
20 984 M
Dividends (Yield)
0.003
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get PerkinElmer Inc data using free add-ons & libraries
Get PerkinElmer Inc Fundamental Data
PerkinElmer Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
PerkinElmer Inc News
New
Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy
Investing.com -- Goldman Sachs has launched coverage of the Life Sciences Tools sector with a selective stance, arguing that the group should ultimately “return to their historic market growth rate ...
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis
HENDERSON, Nev., Dec. 4, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the inclusion of its Nu.Q® NETs H3.1 assay i...
3 Unpopular Stocks with Open Questions
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps ...
Revvity (RVTY): Evaluating Valuation Following Latest Financial Results and Share Price Rebound
Revvity (RVTY) shares have drawn investor attention after the company released its latest financial results, which highlight annual growth in both revenue and net income. The market is reacting to the...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
